Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government.
| Revenue (TTM) | $94.19B |
| Gross Profit (TTM) | $64.13B |
| EBITDA | $33.84B |
| Operating Margin | 24.00% |
| Return on Equity | 35.00% |
| Return on Assets | 8.68% |
| Revenue/Share (TTM) | $39.13 |
| Book Value | $33.87 |
| Price-to-Book | 6.95 |
| Price-to-Sales (TTM) | 6.02 |
| EV/Revenue | 6.31 |
| EV/EBITDA | 14.49 |
| Quarterly Earnings Growth (YoY) | 48.60% |
| Quarterly Revenue Growth (YoY) | 9.10% |
| Shares Outstanding | $2.41B |
| Float | $2.41B |
| % Insiders | 0.06% |
| % Institutions | 75.75% |
Volatility is currently contracting